Ethanol inhibits in-vitro metabolism of nifedipine, triazolam and testosterone in human liver microsomes

Journal of Pharmacy and Pharmacology

Volumn 56, Issue 8, 2004, Pages 963-966

  Patki, Kiran C ^a   Greenblatt, David J ^a   von Moltke, Lisa L ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CYTOCHROME P450 3A; DRUG METABOLITE; HYDROXYCORTICOSTEROID; NIFEDIPINE; TESTOSTERONE; TRIAZOLAM;

ALCOHOL BLOOD LEVEL; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG ALCOHOL INTERACTION; DRUG METABOLISM; DRUG TRANSFORMATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IC 50; IN VITRO STUDY; IN VIVO STUDY; LIVER MICROSOME;

ANDROGENS; ANTI-ANXIETY AGENTS; ARYL HYDROCARBON HYDROXYLASES; BIOTRANSFORMATION; CELLS, CULTURED; CYTOCHROME P-450 CYP3A; DRUG INTERACTIONS; ETHANOL; HUMANS; HYDROXYLATION; MICROSOMES, LIVER; NIFEDIPINE; OXIDOREDUCTASES, N-DEMETHYLATING; TESTOSTERONE; TRIAZOLAM; VASODILATOR AGENTS;

EID: 4344588999     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357043950     Document Type: Article

References (37)

1. Abernethy, D. R., Greenblatt, D. J., Ochs, H. R., Shader, R. I. (1984) Benzodiazepine drug-drug interactions commonly occurring in clinical practice. Curr. Med. Res. Opin. 8: (Suppl. 4): 80-93
2. Auty, R. M., Branch, R. A. (1977) Pharmacokinetics and pharmacodynamics of ethanol, whiskey, and ethanol with n-propyl, n-butyl, and iso-amyl alcohols. Clin. Pharmacol. Ther. 22: 242-249
3. Barbone, F., McMahon, A. D., Davey, P. G., Morris, A. D., Reid, I. C., McDevitt, D. G., MacDonald, T. M. (1998) Association of road-traffic accidents with benzodiazepine use. Lancet 352: 1331-1336
4. Boje, K. M., Fung, H. L. (1989) Characterization of the pharmacokinetic interaction between nifedipine and ethanol in the rat. J. Pharmacol. Exp. Ther. 249: 567-571
5. Boje, K. M., Dolce, J. A., Fung, H. L. (1984) Oral ethanol ingestion altered nifedipine pharmacokinetics in the rat: a preliminary study. Res. Commun. Chem. Pathol. Pharmacol. 46: 219-226
6. Dorian, P., Sellers, E. M., Kaplan, H. L., Hamilton, C., Greenblatt, D. J., Abernethy, D. (1985) Triazolam and ethanol interaction: kinetic and dynamic consequences. Clin. Pharmacol. Ther. 37: 558-562
7. Feierman, D. E. (1996) Identification of cytochrome P450 3A1/2 as the major P450 isoform responsible for the metabolism of fentanyl by rat liver microsomes. Anesth. Analg. 82: 936-941
8. Feierman, D. E., Lasker, J. M. (1996) Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4. Drug Metab. Dispos. 24: 932-939
9. Feierman, D. E., Melinkov, Z., Nanji, A. A. (2003) Induction of CYP3A by ethanol in multiple in vitro and in vivo models. Alcohol Clin. Exp. Res. 27: 981-988
10. Frias, J., Torres, J. M., Miranda, M. T., Ruiz, E., Ortega, E. (2002) Effects of acute alcohol intoxication on pituitary-gonadal axis hormones, pituitary-adrenal axis hormones, beta-endorphin and prolactin in human adults of both sexes. Alcohol Alcohol. 37:169-173
11. Gigon, P. L., Gram, T. E., Gillette, J. R. (1969) Studies on the rate of reduction of hepatic microsomal cytochrome P-450 by reduced nicotinamide adenine dinucleotide phosphate: effect of drug substrates. Mol. Pharmacol. 5: 109-122
12. Hollister, L. E. (1990) Interactions between alcohol and benzodiazepines. Recent Dev. Alcohol. 8: 233-239
13. Hoshino, U., Kawazaki, H. (1995) Urinary 6b-hydroxycortisol excretion in patients with alcoholic liver disease. Res. Commun. Alcohol Subst. Abuse 16: 116-124
14. Kenworthy, K. E., Bloomer, J. C., Clarke, S. E., Houston, J. B. (1999) CYP3A4 drug interactions: correlation of 10 in vitro probe substrates. Br. J. Clin. Pharmacol. 48: 716-727
15. Khanna, J. M., Chung, S., Ho, G., Shah, G. (1979) Acute metabolic interaction of ethanol and drugs. Curr. Alcohol 7: 93-108
16. Komori, M., Nishio, K., Kitada, M., Shiramatsu, K., Muroya, K., Soma, M., Nagashima, K., Kamataki, T. (1990) Fetus-specific expression of a form of cytochrome P-450 in human livers. Biochemistry 29: 4430-4433
17. Kostrubsky, V. E., Strom, S. C., Wood, S. G., Wrighton, S. A., Sinclair, P. R., Sinclair, J. F. (1995) Ethanol and isopentanol increase CYP3A and CYP2E in primary cultures of human hepatocytes. Arch. Biochem. Biophys. 322: 516-520
18. Krecic-Shepard, M. E., Park, K., Barnas, C., Slimko, J., Kerwin, D. R., Schwartz, J. B. (2000) Race and sex influence clearance of nifedipine: results of a population study. Clin. Pharmacol. Ther. 68: 130-142
19. Midanik, L. T., Room, R. (1992) The epidemiology of alcohol consumption. Alcohol Health Res. World 3: 183-190
20. Ochs, H. R., Greenblatt, D. J., Arendt, R. M., Hubbel, W., Shader, R. I. (1984) Pharmacokinetic noninteraction of triazolam and ethanol. J. Clin. Psychopharmacol. 4: 106-107
21. Patki, K. C., von Moltke, L. L., Greenblatt, D. J. (2003) In-vitro metabolism of midazolam, triazolam, nifedipine and testosterone by human liver microsomes and recombinant cytochromes P450: role of CYP3A4 and CYP3A5. Drug Metab. Dispos. 31: 938-944
22. Qureshi, S., Laganiere, S., Caille, G., Gossard, D., Lacasse, Y., McGilveray, I. (1992) Effect of an acute dose of alcohol on the pharmacokinetics of oral nifedipine in humans. Pharm. Res. 9: 683-686
23. Roberts, B. J., Shoaf, S. E., Song, B. J. (1995) Rapid changes in cytochrome P4502E1 (CYP2E1) activity and other P450 isozymes following ethanol withdrawal in rats. Biochem. Pharmacol. 49: 1665-1673
24. Ross, A. D., Varghese, G., Oporto, B., Carmichael, F. J., Israel, Y. (1995) Effect of propylthiouracil treatment on NADPH-cytochrome P450 reductase levels, oxygen consumption and hydroxyl radical formation in liver microsomes from rats fed ethanol or acetone chronically. Biochem. Pharmacol. 49: 979-989
25. Rubin, E., Gang, H., Misra, P. S., Lieber, C. S. (1970) Inhibition of drug metabolism by acute ethanol intoxication. A hepatic microsomal mechanism. Am. J. Med. 49: 801-806
26. Sarkola, T., Eriksson, C. J. (2003) Testosterone increases in men after a low dose of alcohol. Alcohol Clin. Exp. Res. 27: 682-685
27. Sarkola, T., Fukunaga, T., Makisalo, H., Peter Eriksson, C. J. (2000) Acute effect of alcohol on androgens in premenopausal women. Alcohol Alcohol. 35: 84-90
28. Sarkola, T., Adlercreutz, H., Heinonen, S., Eriksson, C. J. (2001a) Alcohol intake, androgen and glucocorticoid steroids in premenopausal women using oral contraceptives: an interventional study. J. Steroid Biochem. Mol. Biol. 78: 157-165
29. Sarkola, T., Adlercreutz, H., Heinonen, S., von der Pahlen, B., Eriksson, C. J. (2001b) The role of the liver in the acute effect of alcohol on androgens in women. J. Clin. Endocrinol. Metab. 86: 1981-1985
30. Sellers, E. M., Greenblatt, D. J., Zilm, D. H., Degani, N. (1978) Decline in chlordiazepoxide plasma levels during fixed-dose therapy of alcohol withdrawal. Br. J. Clin. Pharmacol. 6: 370-372
31. Steentoft, A., Worm, K. (1993) Cases of fatal triazolam poisoning. J. Forensic Sci. Soc. 33: 45-48
32. Tanaka, E. (2002) Toxicological interactions between alcohol and benzodiazepines. J. Toxicol. Clin. Toxicol. 40: 69-75
33. Thummel, K. E., Slattery, J. T., Nelson, S. D., Lee, C. A., Pearson, P. G. (1989) Effect of ethanol on hepatotoxicity of acetaminophen in mice and on reactive metabolite formation by mouse and human liver microsomes. Toxicol. Appl. Pharmacol. 100: 391-397
34. Voas, R. B., Scott Tippetts, A., Fell, J. C. (2003) Assessing the effectiveness of minimum legal drinking age and zero tolerance laws in the United States. Accid. Anal. Prev. 35: 579-587
35. von Moltke, L. L., Greenblatt, D. J., Harmatz, J. S., Shader, R. I. (1993) Alprazolam metabolism in vitro: studies of human, monkey, mouse, and rat liver microsomes. Pharmacology 47: 268-276
36. von Moltke, L. L., Greenblatt, D. J., Harmatz, J. S., Duan, S. X., Harrel, L. M., Cotreau-Bibbo, M. M., Pritchard, G. A., Wright, C. E., Shader, R. I. (1996) Triazolam biotransformation by human liver microsomes in vitro: effects of metabolic inhibitors and clinical confirmation of a predicted interaction with ketoconazole. J. Pharmacol. Exp. Ther. 276: 370-379
37. von Moltke, L. L., Greenblatt, D. J., Grassi, J. M., Granda, B. W., Duan, S. X., Fogelman, S. M., Daily, J. P., Harmatz, J. S., Shader, R. I. (1998) Protease inhibitors as inhibitors of human cytochromes P450: high risk associated with ritonavir. J. Clin. Pharmacol. 38: 106-111